Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (140)
  2. Journal Article (96)
  3. Book Section (8)
  4. Review (8)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (256)
  2. Department of Medicine (256)
  3. Solid Tumor Oncology Division (256)
  4. Survivorship Research (256)
  5. Epidemiology and Biostatistics (102)
  6. Biostatistics Service (87)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (9)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (79)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (17)
  6. Future Medicine (5)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ambient artificial intelligence scribes in oncology: Adoption, feasibility, acceptability, and appropriateness
    Journal Article

    Baldwin-Medsker, A. E.; Chimonas, S.; Goyal, S. P.; Watson, A. J.; Damstrom, M. R.; Kuperman, G. J.; Traina, T.; Roman, B. R.; Stetson, P. D.; Lipitz-Snyderman, A.
    Applied Clinical Informatics (2025)

    Fulltext@MSK | Save
  • Datopotamab deruxtecan-associated select adverse events: Clinical practices and institutional protocols on prophylaxis, monitoring, and management
    Review

    Lisberg, A.; Huppert, L. A.; Halmos, B.; Ledezma, B.; Soto-Romano, V.; Traina, T. A.
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Expert perspectives on controversies and critical knowledge gaps in breast cancer management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium
    Review

    Jhaveri, K.; Anders, C. K.; Bardia, A.; Bhave, M.; Chien, A. J.; Krop, I.; Traina, T. A.; Abdou, Y.; Basho, R.; Conlin, A. K.; more...
    Clinical Breast Cancer (2025)

    Fulltext@MSK | Save
  • TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
    Meeting Abstract

    Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen
    Meeting Abstract

    Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment-related neutropenia as a predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
    Meeting Abstract

    Fanucci, K.; Dueck, A. C.; Mayer, E. L.; Martin, M.; Haddad, T. C.; Zdenkowski, N.; Steger, G. G.; Novik, Y.; Suga, J. M.; Lemieux, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Optimizing postneoadjuvant treatment of residual breast cancer with adjuvant bevacizumab alone, with metronomic or standard-dose chemotherapy: A combined analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE clinical trials
    Journal Article

    Trapani, D.; Jin, Q.; Miller, K. D.; Rugo, H. S.; Reeder-Hayes, K. E.; Traina, T.; Abdou, Y.; Falkson, C.; Abramson, V.; Ligibel, J.; more...
    Clinical Breast Cancer (2025)

    Fulltext@MSK | Save
  • Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
    Journal Article

    Shinn, E.; Zahrieh, D.; DeMichele, A.; Zdenkowski, N.; Lemieux, J.; Mao, J.; Bjelic-Radisic, V.; Naughton, M. J.; Pfeiler, G.; Gelmon, K.; more...
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])
    Journal Article

    DeMichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H.; Pfeiler, G.; Zdenkowski, N.; Wolff, A.; Bellet-Ezquerra, M.; Winer, E.; more...
    Breast Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II study of nivolumab, ipilimumab plus bicalutamide in metastatic breast cancer
    Meeting Abstract

    Page, D. B.; Kaur, L.; Hong, E. C. C.; Su, A.; Moxon, N.; Mellinger, S.; Kelly, T.; Kelley, A.; Fredrich, N.; Seino, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save